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endoscopic sphincterotomy plus large-balloon
dilation for the treatment of large bile duct
stones
Jae Chul Hwang, Jin Hong Kim*, Sun Gyo Lim, Soon Sun Kim, Sung Jae Shin, Kee Myung Lee and Byung Moo YooAbstract
Background: Endoscopic sphincterotomy (EST) combined with large-balloon dilation (LBD) has been proposed as
an alternative to manage large bile duct stones. However, recent reports indicate that LBD without EST may be safe
and effective in this setting.
Methods: One hundred thirty-one patients with large common bile duct (CBD) stones 12 mm in size or larger
underwent LBD alone (n = 62) or EST plus LBD (n = 69) for lithotripsy. The therapeutic outcome and complications
were reviewed and compared.
Results: There were no differences between the two groups with regard to age, size and number of stones, or bile
duct diameter. The LBD alone group (mean age, 70.4 years) and the EST plus LBD group (mean age, 68.2 years) had
similar outcomes in terms of overall successful stone removal (96.8% vs. 95.7%, P = 0.738) and complete stone
removal without the need for mechanical lithotripsy (80.6% vs. 73.9%, P = 0.360). Complications in the LBD alone
and EST plus LBD groups were as follows: pancreatitis (6.5% vs. 4.3%, P = 0.593), impaction of basket and stone
(0% vs. 1.4%, P = 0.341), and perforation (0% vs. 1.4%, P = 0.341).
Conclusions: LBD alone may be a simple, safe, and effective alternative to EST plus LBD in relatively aged patients
with large CBD stones, and it can simplify the procedure compared with EST plus LBD.
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Endoscopic retrograde cholangiopancreatography (ERCP)
has become one of the most important techniques in the
treatment of bile duct stones. It is usually combined with
endoscopic sphincterotomy (EST) to extract bile duct
stones using a standard balloon or basket catheter. Alter-
natively, endoscopic papillary balloon dilatation (EPBD)
has been proposed for this indication because it is thought
to preserve the function of the sphincter of Oddi and lessen
the complications seen with EST, such as hemorrhage and
perforation [1-4]. EPBD is technically easier than EST, espe-
cially if sphincterotome control is difficult, the margin for
cutting is limited, or the appropriate cutting direction is in* Correspondence: jinhkim@ajou.ac.kr
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reproduction in any medium, provided the orquestion [5]. However, EPBD has been associated with a
higher risk of pancreatitis after ERCP [6-8].
Large bile duct stones appear to be more difficult to re-
move with conventional methods, such as EST and EPBD.
Therefore, extraction of large bile duct stones may require
mechanical lithotripsy (ML) as an adjunctive procedure,
which likely lengthens the procedure time. A number of
studies have been conducted using large-balloon dilation
(LBD) after adequate EST to extract large bile duct stones
[9-13]. In those studies, the authors suggested that EST
plus LBD might lower the risk of postprocedure pan-
creatitis by directing balloon dilation toward the bile duct
rather than the pancreatic duct [9-13]. However, recent
studies have shown that LBD without preceding EST is
safe and effective in patients with large common bile duct
(CBD) stones [14,15]. We conducted the present study toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tween LBD alone and EST plus LBD for the treatment of
large bile duct stones.
Methods
The ERCP database at our institution was searched for
prospectively collected data on patients with large bile
duct stones who underwent LBD from March 2004 to
April 2009. During the study period, 2665 ERCPs were
performed at our institution. The patients were identi-
fied from the database using a search query and the
medical records of the patients were reviewed using
a standardized data entry form. From March 2004 to
February 2008, LBD was routinely performed with EST,
while LBD alone (without EST) was performed from
March 2008 to April 2009. LBD without EST was intro-
duced into this hospital in March 2008 and used for the
treatment of large bile duct stones. We have conducted
a prospective, randomized, comparative study to validate
LBD without EST as an effective and safe treatment for
endoscopic removal of large bile duct stones since May
2009. We analyzed the data before and after the omis-
sion of EST to investigate its effect on the success of
stone clearance and complications. Patients with visua-
lized bile duct stones ≥12 mm in maximum transverse
diameter were included. Exclusion criteria were (1) bleed-
ing diathesis, (2) prior EST or EPBD, (3) Billroth II or
Roux-en-Y anatomy, (4) distal extrahepatic bile duct ste-
nosis, (5) acute pancreatitis, and (6) intrahepatic bile duct
stones. Based on these criteria, 62 patients were included
in the LBD alone group and 69 patients were included in
the EST plus LBD group. This study was approved by our
institutional review board, and informed consent was
obtained from all patients for the endoscopic procedures
performed.
ERCP was performed with side-viewing endoscopes
(Olympus JF-240 or TJF-240; Olympus Optical Co., Ltd.,
Tokyo, Japan). Each patient was sedated with a standard
dose of midazolam, propofol, and meperidine. After the
CBD was selectively cannulated using a sphincterotome,
an initial cholangiogram was taken. Diameters of the bile
duct and stones were measured during ERCP and cor-
rected for magnification using the external diameter of
the duodenoscope’s distal end as a reference. In the EST
plus LBD group, EST was performed before LBD from
the orifice of the papilla proximally to the transverse fold
(minor EST). Wire-guided hydrostatic balloon catheters
(Boston Scientific Microvasive, Cork, Ireland) that can
be dilated to the three distinct diameters listed on the
package and hub labels were positioned across the major
papilla with the balloon mid-portions placed at the
biliary sphincter. The balloon was then gradually inflated
to the pressure corresponding to the smallest balloon
diameter with dilute contrast medium until the waist ofthe balloon had disappeared under fluoroscopic guid-
ance. Thereafter, the pressure for inflation of the balloon
was gradually increased until the desired dilation was
achieved. Once the dilation to the desired diameter was
achieved, the balloon was maintained in position for
60 seconds and then deflated and removed. The balloon
diameters used were 12 to 20 mm, and the diameter of
the balloon was selected according to the sizes of the
stones and bile duct proximal to the tapered segment
under fluoroscopic guidance. The bile duct stones were
removed with a Dormia basket or retrieval balloon
(Figures 1 and 2). A mechanical lithotripter was used to
fragment the stones when standard methods failed to
remove the stones, even after LBD.
Technical success was defined as complete removal of all
CBD stones after LBD without the need for ML. Serum
amylase, total bilirubin, and alkaline phosphatase levels;
complete blood counts; and abdominal radiographs were
checked before procedures and on the following day to
monitor for complications such as bleeding, perforation,
acute pancreatitis, and acute cholangitis. Complications
were evaluated according to 1991 consensus guidelines [16]
defining post-ERCP pancreatitis as persistent epigastric
pain of >24 hours with a ≥3-fold elevation in serum amyl-
ase concentration after the procedure.
Statistical analysis was performed using the chi-square
test or Fisher’s exact test for categorical parameters and
Student’s t test for continuous variables. Analyses were
performed using SPSS 12.0 (SPSS Inc., Chicago, IL), with
quantitative data presented as mean ± standard deviation.
Statistical significance was set at a P value of <0.05.
Results
Demographic data for the 131 patients included in the
study are summarized in Table 1. There were no signifi-
cant differences between the two groups with regard to
age, periampullary diverticulum, size and number of
stones, or bile duct diameter.
LBD with or without EST was successfully performed
in all patients. The mean diameter of the balloon used
for LBD was 15.9 mm (range, 12–20 mm) for the LBD
alone group and 16.2 mm (range, 12–20 mm) for the
EST plus LBD group (P = 0.444). The overall stone clear-
ance was ultimately similar between the LBD alone
group (96.8%) and the EST plus LBD group (95.7%)
whether or not ML was used (P = 0.738) (Table 2). The
technical success rate was 80.6% in the LBD alone group
and in 73.9% in the EST plus LBD group (P = 0.360).
Complete stone clearance was not feasible during the
first session in nine patients (five patients in the LBD
alone group vs. four patients in the EST plus LBD group,
P = 0.608). Failure of complete duct clearance occurred
in five patients (two patients in the LBD alone group,
three patients in the EST plus LBD group) despite the
Figure 1 Endoscopic view of large-balloon dilation without biliary sphincterotomy. A. Guidewire positioned across the papilla. B. Large
balloon inflated across the papilla without preceding endoscopic sphincterotomy. C. Markedly dilated papilla after large-balloon dilation. D. Large
stone extracted with a basket through the dilated papilla.
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stone impaction and incomplete stone capture with the
basket. These patients underwent percutaneous transhe-
patic cholangioscopy to remove the stones, with the
exception of one patient who required surgery in the
EST plus LBD group.
When the two study groups were further divided by
success or failure of complete stone removal after LBD
(without the need for ML), significant differences were
observed with regard to the stone size (LBD alone: 14.6 ±
2.1 mm vs. 20.2 ± 3.5 mm, P < 0.001; EST plus LBD: 15.5 ±
2.9 mm vs. 19.4 ± 5.9 mm, P < 0.001) and the balloon/stone
diameter ratio (LBD alone: 1.01 ± 0.10 vs. 0.82 ± 0.08, P <
0.001; EST plus LBD: 1.15 ± 0.19 vs. 0.90 ± 0.18, P < 0.001)
(Table 3).
Post-ERCP complications are summarized in Table 4.
Rates of pancreatitis did not differ significantly between
the two groups (6.5% vs. 4.3%, P = 0.593), and these cases
were mild and self-limiting. Perforation was observed in
one patient in the EST plus LBD group. This complication
was found shortly after complete stone clearance, and the
patient recovered uneventfully following surgical interven-
tion. In another patient in the EST plus LBD group, the
basket was broken on a hard stone during ML, and a por-
tion of the broken basket was retained in the bile duct.The patient subsequently underwent bile duct explo-
ration with a satisfactory outcome. No clinically signifi-
cant hemorrhage occurred in either group.
Discussion
In the current study, LBD without EST was as effective
and safe as EST plus LBD in patients with large bile duct
stones. To our knowledge, this is the first study to com-
pare the efficacy and safety of LBD alone with EST plus
LBD for the treatment of large bile duct stones.
EPBD was originally devised to extract CBD stones while
minimizing damage to the sphincter of Oddi. However, the
drawback of EPBD compared with EST is the more limited
size of the papillary opening. Approximately 10% of bile
duct stones are difficult to remove using conventional
techniques, and for these patients, ML is generally the next
step [17-19]. However, ML is time-consuming, has a po-
tential for injury of the EST site or bile duct, and may be
complicated by impaction of the stone-capturing basket.
Moreover, because small stone fragments after ML may act
as nidi for stone recurrence, ML is one of the risk factors
for recurrent bile duct stones after endoscopic stone ex-
traction [20]. The main purpose of LBD is to avoid or
lessen the use of ML for removal of large CBD stones and
to reduce complications that may be related to ML.
Figure 2 Fluoroscopic view of large-balloon dilatation without
biliary sphincterotomy. A. Cholangiogram demonstrating a large
stone within the dilated bile duct. B. Large balloon inflated across
over guidewire. The diameter of the balloon was selected according
to the diameter of the stone and of the bile duct proximal to the
tapered segment under fluoroscopic guidance. C. The stone was
captured in a basket. D. Cholangiogram after complete stone
removal showed no residual filling defect in the bile duct.









15.9 ± 2.3 (12-20) 16.2 ± 2.5 (12-20) 0.444
Complete stone
removal irrespective
of whether ML was
used, no. (%)




50 (80.6) 51 (73.9) 0.360
LBD: Large-balloon dilation; EST: Endoscopic sphincterotomy; ML: Mechanical
lithotripsy.
Continuous variables are expressed as mean ± standard deviation (range).
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by EPBD with large-diameter (12–20 mm) balloons as
an alternative technique for bile duct stones that are dif-
ficult to remove by standard methods. Complete stone
retrieval without ML was successful in 54 (93.1%) of 58
patients, and stone clearance was achieved by ML in 4
(6.9%) patients. Complications occurred in nine patients
(15.5%), including two (3.4%) with mild pancreatitis.Table 1 Baseline clinical characteristics of the patients
LBD alone EST plus LBD P value
(n = 62) (n = 69)
Gender (male/female) 23/39 33/36 0.215
Age (years) 70.4 ± 10.9 68.2 ± 10.5 0.902
Periampullary 33 (53.2) 38 (55.1) 0.832
diverticulum, no. (%)
Cholecystectomy, no. (%) 16 (25.8) 18 (26.1) 0.971
Bile duct stones
Size (mm)a 15.7 ± 3.3 16.5 ± 4.2 0.182
Number 2.3 ± 1.6 2.8 ± 1.8 0.109
Bile duct size (mm)b 20.5 ± 4.4 21.4 ± 4.6 0.996
LBD: Large-balloon dilation; EST: Endoscopic sphincterotomy.
Continuous variables are expressed as mean ± standard deviation.
a Maximum transverse diameter of the largest stone.
b Maximum transverse diameter of the bile duct proximal to the tapered
segment of the distal common bile duct.Several studies have since been conducted using EST plus
LBD for large, difficult bile duct stones [10-13,21,22].
Figures for overall stone clearance have ranged from 95%
to 100%, with ML required for 1% to 27%. Complication
rates have also varied from 0% to 8.3%, with pancreatitis
between 0% and 4.5%. In most previous studies using EST
plus LBD for removal of large CBD stones [9-13,21,22],
the authors suggested that this technique may be asso-
ciated with a lower risk of pancreatitis because EST prior
to LBD may result in separation between the pancreatic
and biliary orifices, and it can guide the direction of bal-
loon dilation toward the bile duct rather than the pancre-
atic duct during LBD. However, recent two studies
indicate that LBD without EST may be safe and effective
in patients with large CBD stones [14,15]. In a retros-
pective preliminary study [14], overall successful stone
removal was achieved in 37 (97.4%) of 38 patients, and
ML was required in 8 (21.1%) patients. A mild degree of
postprocedure pancreatitis developed in only one (2.6%)
patient. The authors proposed that a prior EST before
LBD may not play an important role in the guidance of
balloon dilation toward the bile duct. They also suggested
that ML may induce papillary edema or spasms that may
obstruct the pancreatic duct orifice. Thus, LBD may lower
the incidence of pancreatitis by reducing the need for ML
when removing large bile duct stones. In addition, because
LBD is not performed on a nondilated CBD, which is one
of the risk factors for post-ERCP pancreatitis, LBD may
not carry the same risk of postprocedure pancreatitis as
EPBD with a balloon catheter diameter of ≤10 mm for the
removal of CBD stones [14]. In another retrospective
study [15], overall complete stone clearance was achieved
in 229 (92.7%) of 247 patients, and ML was needed in
39 (15.8%) patients while retrieving the stones. There were
nine (3.6%) complications, including two (0.8%) cases of
mild pancreatitis. In the present study, the rates of overall
stone clearance and complete stone removal without ML
were similar between the two groups (96.8% vs. 95.7%,
P = 0.738; and 80.6% vs. 73.9%, P = 0.360, respectively).
Table 3 Comparison of clinical characteristics between the success and failure groups
LBD alone (n = 62) EST plus LBD (n = 69)
Success group (n = 50)a Failure group (n = 12)b P value Success group (n = 51)a Failure group (n = 18)b P value
Bile duct stones
Size (mm) 14.6 ± 2.1 20.2 ± 3.5 <0.001 15.5 ± 2.9 19.4 ± 5.9 <0.001
Number 2.2 ± 1.7 2.9 ± 1.2 0.166 2.8 ± 1.8 3.0 ± 1.9 0.609
Balloon/stone diameter
ratio
1.01 ± 0.10 0.82 ± 0.08 <0.001 1.15 ± 0.19 0.90 ± 0.18 <0.001
LBD: Large-balloon dilation; EST: Endoscopic sphincterotomy.
a Complete stone clearance without mechanical lithotripsy.
b Application of mechanical lithotripsy or failure to extract stone even after LBD.
Continuous variables are expressed as mean ± standard deviation.
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groups (6.5% vs. 4.3%, P = 0.593), and all cases were mild
and self-limiting. The progressive decline in pancreatic
exocrine function with aging may protect older patients
from pancreatic injury, and one meta-analysis comparing
EST and EPBD for bile duct stones demonstrated that age
of <60 years was one of the factors related to a higher rate
of pancreatitis in patients with EPBD [23,24]. Therefore,
the relatively old age of the patients in the current study
may explain these results.
An additional purpose of LBD is to reduce complica-
tions by avoiding full-incision EST (major EST) in patients
with large CBD stones. Although the reported bleeding
rates from previous studies involving LBD range from
0% to 9% [9-15,21], several reports on the performance of
major EST before LBD showed a relatively high incidence
of bleeding (8.3%–9%) [9,11]. In this study, minor EST
was performed before LBD in the EST plus LBD group
and clinically significant hemorrhage was not noted in
either group.
Other complications occurred in two patients in the
EST plus LBD group. Perforation resulting from a duo-
denal wall tear opposite the major papilla occurred in one
patient. It occurred during stone removal with a basket
after LBD and ML and was caused by the tip of the duo-
denoscope. This complication was found shortly after
complete stone removal. A basket impaction occurred in








Pancreatitis 4 3 0.593
Bleeding 0 0
Perforation 0 1 0.341
Embedded broken basket after
ML
0 1 0.341
Total 4 5 0.858
LBD: Large-balloon dilation; EST: Endoscopic sphincterotomy.broken during ML, and a portion of the broken basket
remained in the bile duct. These complications were not
related to LBD, and both patients recovered with surgical
intervention.
Previous definitions of technical success have varied by
publication [9-13,21]. To define technical success, the
frequency of required examinations may be used, but is
often subject to the endoscopist. Moreover, the goal of
LBD in managing large CBD stones is to avert ML and its
potential complications. In the present study, we defined
technical success as complete removal of CBD stones by
performing LBD without an additional procedure such as
ML, and we did not take into account the number of
endoscopic sessions. In a retrospective study of LBD alone
for retrieval of large CBD stones [14], patients in the treat-
ment failure group showed a tendency to have a greater
transverse stone diameter and smaller balloon/stone
diameter ratio than patients in the treatment success
group (20.8 ± 6.5 mm vs. 16.7 ± 3.9 mm [P = 0.077] and
0.80 ± 0.23 vs. 0.96 ± 0.19 [P = 0.066], respectively). In an-
other retrospective multicenter study of EST plus LBD for
bile duct stone removal [13], the median maximum stone
size in patients undergoing ML was significantly larger
than that in patients who did not undergo ML (16.7 vs.
13.3 mm, P < 0.01). In this study, treatment failure was
associated with larger transverse stone diameters com-
pared with treatment success and smaller balloon/stone
diameter ratios. These results suggest that ML is more
frequently used with larger stone sizes and that using a
balloon catheter with a diameter smaller than the max-
imum transverse diameter of the stone causes resistance
at the ampullary opening during stone removal with a bas-
ket or retrieval balloon catheter. Thus, the diameter of the
balloon should exceed the maximum transverse diameter
of the stone, but not the diameter of the bile duct.
Our patient group is small and the study was limited by
its retrospective nature. Moreover, our study included
many older patients who may be related to a lower rate of
postprocedure pancreatitis. Therefore, the efficacy and
safety of LBD alone in relatively young patients with large
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paring LBD alone and EST plus LBD should be conducted
in order to confirm our results.
Conclusions
LBD alone may be a simple, safe, and effective alterna-
tive to EST plus LBD in relatively aged patients with
large CBD stones, and it can simplify the procedure
compared with EST plus LBD.
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